0001127602-17-011528.txt : 20170314
0001127602-17-011528.hdr.sgml : 20170314
20170314134743
ACCESSION NUMBER: 0001127602-17-011528
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170310
FILED AS OF DATE: 20170314
DATE AS OF CHANGE: 20170314
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAAB THOMAS R II
CENTRAL INDEX KEY: 0001230708
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 17687659
MAIL ADDRESS:
STREET 1: C/O INSPIRE PHARMACEUTICALS, INC.
STREET 2: 4222 EMPEROR BLVD., SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-03-10
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001230708
STAAB THOMAS R II
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Senior Vice President and CFO
Common Stock
2017-03-10
4
M
0
3250
3.78
A
120563
D
Common Stock
2017-03-10
4
S
0
3250
9.06
D
117313
D
Emp. Stock Option (Right to Buy)
3.78
2017-03-10
4
M
0
3250
0
D
2012-07-01
2021-07-01
Common Stock
3250
83010
D
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2016.
The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $9.02 to $9.10. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
/s/ Alane P. Barnes, by power of attorney
2017-03-14